PFBT
VNDA icon

Parkside Financial Bank & Trust’s Vanda Pharmaceuticals VNDA Stock Holding History

Parkside Financial Bank & Trust’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-19
Closed -$126 – 2112
2023
Q2 		$126 Sell
19
-607
-97% -$3.89K ﹤0.01% 1985
2023
Q1 		$4.25K Buy
626
+284
+83% +$2K ﹤0.01% 1422
2022
Q4 		$2.53K Hold
342
– – ﹤0.01% 1599
2022
Q3 		$3K Buy
+342
New +$3.61K ﹤0.01% 1466
2022
Q2 		– Sell
-13
Closed – – 1967
2022
Q1 		$0 Sell
13
-257
-95% -$3.38K ﹤0.01% 1945
2021
Q4 		$4K Buy
270
+133
+97% +$2.32K ﹤0.01% 1434
2021
Q3 		$2K Sell
137
-16
-10% -$280 ﹤0.01% 1610
2021
Q2 		$3K Buy
153
+16
+12% +$286 ﹤0.01% 1474
2021
Q1 		$2K Hold
137
– – ﹤0.01% 1538
2020
Q4 		$2K Buy
+137
New +$1.65K ﹤0.01% 1460
2020
Q3 		– Sell
-30
Closed – – 1658
2020
Q2 		$0 Sell
30
-4
-12% -$45 ﹤0.01% 1708
2020
Q1 		$0 Sell
34
-39
-53% -$484 ﹤0.01% 1669
2019
Q4 		$1K Hold
73
– – ﹤0.01% 1492
2019
Q3 		$1K Hold
73
– – ﹤0.01% 1469
2019
Q2 		$1K Buy
73
+13
+22% +$207 ﹤0.01% 1482
2019
Q1 		$1K Buy
60
+16
+36% +$365 ﹤0.01% 1441
2018
Q4 		$1K Buy
+44
New +$1.03K ﹤0.01% 1341

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Parkside Financial Bank & Trust's VNDA Position: Q3 2023 in Review

Parkside Financial Bank & Trust sold out of Vanda Pharmaceuticals (VNDA) in Q3 2023, closing a stake of 19 shares — an estimated $126 sold.

Parkside Financial Bank & Trust first reported a position in VNDA in Q4 2018 and held it in 17 quarters. The position peaked at $4.25K in Q1 2023. 179 funds tracked by Wall St. Rank hold VNDA as of Q3 2023.

  • Parkside Financial Bank & Trust reported no remaining Vanda Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 19 Vanda Pharmaceuticals shares in Q3 2023, an estimated $126.
  • Parkside Financial Bank & Trust first reported a position in Vanda Pharmaceuticals in Q4 2018 and held it in 17 quarters.
  • Parkside Financial Bank & Trust's Vanda Pharmaceuticals position peaked at $4.25K in Q1 2023.
  • 179 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2023.

Based on Parkside Financial Bank & Trust's 13F filing for Q3 2023, filed 13 Nov 2023.